Tenofovir alafenamide for hepatitis B: evolution or revolution?
Lancet Gastroenterol Hepatol
.
2016 Nov;1(3):174-175.
doi: 10.1016/S2468-1253(16)30083-8.
Epub 2016 Sep 22.
Author
Willem P Brouwer
1
Affiliation
1
Department of Gastroenterology and Hepatology, Erasmus University Medical Center Rotterdam, 3015 CE Rotterdam, Netherlands. Electronic address: w.p.brouwer@erasmusmc.nl.
PMID:
28404084
DOI:
10.1016/S2468-1253(16)30083-8
No abstract available
Publication types
Comment
MeSH terms
Anti-HIV Agents
Antiviral Agents
HIV Infections
Hepatitis B*
Hepatitis B, Chronic
Humans
Tenofovir*
Substances
Anti-HIV Agents
Antiviral Agents
Tenofovir